Cargando…

Antimicrobial and anti-biofilm potencies of dermcidin-derived peptide DCD-1L against Acinetobacter baumannii: an in vivo wound healing model

BACKGROUND: The global emergence of Acinetobacter baumannii resistance to most conventional antibiotics presents a major therapeutic challenge and necessitates the discovery of new antibacterial agents. The purpose of this study was to investigate in vitro and in vivo anti-biofilm potency of dermcid...

Descripción completa

Detalles Bibliográficos
Autores principales: Farshadzadeh, Zahra, Pourhajibagher, Maryam, Taheri, Behrouz, Ekrami, Alireza, Modarressi, Mohammad Hossein, Azimzadeh, Masoud, Bahador, Abbas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8756727/
https://www.ncbi.nlm.nih.gov/pubmed/35026999
http://dx.doi.org/10.1186/s12866-022-02439-8
_version_ 1784632619544084480
author Farshadzadeh, Zahra
Pourhajibagher, Maryam
Taheri, Behrouz
Ekrami, Alireza
Modarressi, Mohammad Hossein
Azimzadeh, Masoud
Bahador, Abbas
author_facet Farshadzadeh, Zahra
Pourhajibagher, Maryam
Taheri, Behrouz
Ekrami, Alireza
Modarressi, Mohammad Hossein
Azimzadeh, Masoud
Bahador, Abbas
author_sort Farshadzadeh, Zahra
collection PubMed
description BACKGROUND: The global emergence of Acinetobacter baumannii resistance to most conventional antibiotics presents a major therapeutic challenge and necessitates the discovery of new antibacterial agents. The purpose of this study was to investigate in vitro and in vivo anti-biofilm potency of dermcidin-1L (DCD-1L) against extensively drug-resistant (XDR)-, pandrug-resistant (PDR)-, and ATCC19606-A. baumannii. METHODS: After determination of minimum inhibitory concentration (MIC) of DCD-1L, in vitro anti-adhesive and anti-biofilm activities of DCD-1L were evaluated. Cytotoxicity, hemolytic activity, and the effect of DCD-1L treatment on the expression of various biofilm-associated genes were determined. The inhibitory effect of DCD-1L on biofilm formation in the model of catheter-associated infection, as well as, histopathological examination of the burn wound sites of mice treated with DCD-1L were assessed. RESULTS: The bacterial adhesion and biofilm formation in all A. baumannii isolates were inhibited at 2 × , 4 × , and 8 × MIC of DCD-1L, while only 8 × MIC of DCD-1L was able to destroy the pre-formed biofilm in vitro. Also, reduce the expression of genes involved in biofilm formation was observed following DCD-1L treatment. DCD-1L without cytotoxic and hemolytic activities significantly reduced the biofilm formation in the model of catheter-associated infection. In vivo results showed that the count of A. baumannii in infected wounds was significantly decreased and the promotion in wound healing by the acceleration of skin re-epithelialization in mice was observed following treatment with 8 × MIC of DCD-1L. CONCLUSIONS: Results of this study demonstrated that DCD-1L can inhibit bacterial attachment and biofilm formation and prevent the onset of infection. Taking these properties together, DCD-1L appears as a promising candidate for antimicrobial and anti-biofilm drug development.
format Online
Article
Text
id pubmed-8756727
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-87567272022-01-18 Antimicrobial and anti-biofilm potencies of dermcidin-derived peptide DCD-1L against Acinetobacter baumannii: an in vivo wound healing model Farshadzadeh, Zahra Pourhajibagher, Maryam Taheri, Behrouz Ekrami, Alireza Modarressi, Mohammad Hossein Azimzadeh, Masoud Bahador, Abbas BMC Microbiol Research BACKGROUND: The global emergence of Acinetobacter baumannii resistance to most conventional antibiotics presents a major therapeutic challenge and necessitates the discovery of new antibacterial agents. The purpose of this study was to investigate in vitro and in vivo anti-biofilm potency of dermcidin-1L (DCD-1L) against extensively drug-resistant (XDR)-, pandrug-resistant (PDR)-, and ATCC19606-A. baumannii. METHODS: After determination of minimum inhibitory concentration (MIC) of DCD-1L, in vitro anti-adhesive and anti-biofilm activities of DCD-1L were evaluated. Cytotoxicity, hemolytic activity, and the effect of DCD-1L treatment on the expression of various biofilm-associated genes were determined. The inhibitory effect of DCD-1L on biofilm formation in the model of catheter-associated infection, as well as, histopathological examination of the burn wound sites of mice treated with DCD-1L were assessed. RESULTS: The bacterial adhesion and biofilm formation in all A. baumannii isolates were inhibited at 2 × , 4 × , and 8 × MIC of DCD-1L, while only 8 × MIC of DCD-1L was able to destroy the pre-formed biofilm in vitro. Also, reduce the expression of genes involved in biofilm formation was observed following DCD-1L treatment. DCD-1L without cytotoxic and hemolytic activities significantly reduced the biofilm formation in the model of catheter-associated infection. In vivo results showed that the count of A. baumannii in infected wounds was significantly decreased and the promotion in wound healing by the acceleration of skin re-epithelialization in mice was observed following treatment with 8 × MIC of DCD-1L. CONCLUSIONS: Results of this study demonstrated that DCD-1L can inhibit bacterial attachment and biofilm formation and prevent the onset of infection. Taking these properties together, DCD-1L appears as a promising candidate for antimicrobial and anti-biofilm drug development. BioMed Central 2022-01-13 /pmc/articles/PMC8756727/ /pubmed/35026999 http://dx.doi.org/10.1186/s12866-022-02439-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Farshadzadeh, Zahra
Pourhajibagher, Maryam
Taheri, Behrouz
Ekrami, Alireza
Modarressi, Mohammad Hossein
Azimzadeh, Masoud
Bahador, Abbas
Antimicrobial and anti-biofilm potencies of dermcidin-derived peptide DCD-1L against Acinetobacter baumannii: an in vivo wound healing model
title Antimicrobial and anti-biofilm potencies of dermcidin-derived peptide DCD-1L against Acinetobacter baumannii: an in vivo wound healing model
title_full Antimicrobial and anti-biofilm potencies of dermcidin-derived peptide DCD-1L against Acinetobacter baumannii: an in vivo wound healing model
title_fullStr Antimicrobial and anti-biofilm potencies of dermcidin-derived peptide DCD-1L against Acinetobacter baumannii: an in vivo wound healing model
title_full_unstemmed Antimicrobial and anti-biofilm potencies of dermcidin-derived peptide DCD-1L against Acinetobacter baumannii: an in vivo wound healing model
title_short Antimicrobial and anti-biofilm potencies of dermcidin-derived peptide DCD-1L against Acinetobacter baumannii: an in vivo wound healing model
title_sort antimicrobial and anti-biofilm potencies of dermcidin-derived peptide dcd-1l against acinetobacter baumannii: an in vivo wound healing model
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8756727/
https://www.ncbi.nlm.nih.gov/pubmed/35026999
http://dx.doi.org/10.1186/s12866-022-02439-8
work_keys_str_mv AT farshadzadehzahra antimicrobialandantibiofilmpotenciesofdermcidinderivedpeptidedcd1lagainstacinetobacterbaumanniianinvivowoundhealingmodel
AT pourhajibaghermaryam antimicrobialandantibiofilmpotenciesofdermcidinderivedpeptidedcd1lagainstacinetobacterbaumanniianinvivowoundhealingmodel
AT taheribehrouz antimicrobialandantibiofilmpotenciesofdermcidinderivedpeptidedcd1lagainstacinetobacterbaumanniianinvivowoundhealingmodel
AT ekramialireza antimicrobialandantibiofilmpotenciesofdermcidinderivedpeptidedcd1lagainstacinetobacterbaumanniianinvivowoundhealingmodel
AT modarressimohammadhossein antimicrobialandantibiofilmpotenciesofdermcidinderivedpeptidedcd1lagainstacinetobacterbaumanniianinvivowoundhealingmodel
AT azimzadehmasoud antimicrobialandantibiofilmpotenciesofdermcidinderivedpeptidedcd1lagainstacinetobacterbaumanniianinvivowoundhealingmodel
AT bahadorabbas antimicrobialandantibiofilmpotenciesofdermcidinderivedpeptidedcd1lagainstacinetobacterbaumanniianinvivowoundhealingmodel